LiGHT 2026

Stryker Announces First Patient Case Using New Tornier Perform Patient-Matched Primary Reversed Glenoid

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

WebMD Ignite Ruby Transforms Healthcare Marketing...

WebMD Ignite has announced the launch of WebMD Ignite...

Mayo Clinic Study Validates AI Tool...

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI...

The United Kingdom’s Medicines and Healthcare products Regulatory Agency...

Stryker, one of the world’s leading medical technology companies, announced  that its new Tornier Perform® Patient-Matched Primary Reversed Glenoid (Patient-Matched Glenoid) was used in a surgical procedure for the first time. The case was completed Jan. 13 by Jay Keener, M.D, in St. Louis and will be highlighted in a presentation at the 2022 Advanced Shoulder Arthroplasty (ASAP) Meeting on Jan. 21 in Snowbird, Utah.

The limited-market release Patient-Matched Glenoid is the first surgeon-driven, primary patient-specific implant available in shoulder arthroplasty. Taking into account the surgeon’s surgical preference and patient need, it is a patient-matched implant that is planned on Stryker’s Blueprint® 3D Planning Software.

“The Patient-Matched Glenoid puts surgeons in the driver’s seat to contour the implant to the face of the native glenoid that is unique to each patient’s anatomy,” said Dr. George S. Athwal, one of the designers of the implant system. “The Patient-Matched Glenoid system increases efficiency in the OR, requiring fewer surgical steps and no glenoid bone reaming.”

To generate the Patient-Matched Glenoid, the surgeon uses Blueprint Software to virtually position and execute the creation of a patient-matched implant. Once completed in Blueprint, an order is generated to manufacture the glenoid baseplate and patient-specific instrumentation (PSI). The surgeon will receive the sterile devices and execute the implantation of the baseplate using a ream-free, bone-preserving technique.

“Stryker’s relentless pursuit of innovation is exemplified in the Patient-Matched Glenoid, a strong addition to our upper extremities portfolio,” said Tim Lanier, vice president and general manager of Stryker’s Upper Extremities business. “It will give our customers autonomy that is not available anywhere else in the market.”

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Mayo Clinic Study Validates AI Tool DEXI for Skin Lesion Assessment

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI Medical Devices at AdvaMed

The United Kingdom’s Medicines and Healthcare products Regulatory Agency...

UK Confirms Indefinite Use of CE Marked Medical Devices

The United Kingdom government has officially confirmed the indefinite...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »